Danaher Corporation: Sepsis trials
The registry lists 10 Sepsis studies with Danaher Corporation as lead sponsor. 1 are open to participants now and 0 have results posted.
No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Sepsis Clinical Decision Support [CDS] Master Enrollment Study ProtocolEnrolling by invitationNCT05304728
- Adult MDW Dual Cut-Off Accuracy StudyTerminatedNCT06885528
- Clinical Trial to Evaluate MDW for Early Detection of SepsisActive, not recruitingNCT06267742
- Sepsis Post Market Clinical Utility Simple Endpoint Study - Indiana University HospitalCompletedNCT04819035
- Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMCCompletedNCT04804306
- Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington UniversityCompletedNCT04353388
- Leukocyte MOrphology and CORticosteroids Response in SEPtic Patients (MOCORSEP)CompletedNCT04292431
- Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Baylor S&WCompletedNCT04291417
- Evaluation of MDW for Early Detection of Sepsis, Clinical ValidityCompletedNCT03588325
- Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of SepsisCompletedNCT03145428